Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 2001

View Archived Issues

Combretastatin significantly potentiates the antitumor action of radioimmunotherapy

Phase II study of AC-2993 shows positive results for type 2 diabetes

Nicox's NCX-1000 protects against portal hypertension in preclinical study

ETA receptor antagonist attenuates angiotensin II- and noradrenaline-induced vasoconstriction

EGFR and HER-2 tyrosine kinase inhibitors with in vivo antitumor activity reported

Progesterone antagonists may provide a new option to suppress menstruation

Agreement to commercialize Anogesic announced by Cellegy and Ventiv

Addition of ZD-1839 to conventional maintenance therapy being evaluated in NSCLC patients

Abgenix and Agensys sign cancer immunotherapy collaboration

Long-term results emphasize Pravachol's good safety profile

Xenova and QLT sign licensing agreement for XR-9576

Atrix and HGSI to develop drug using Atrigel delivery system

Cognetix secures financing to further advance research and discovery efforts

Serono's Saizen approved in E.U. for treatment of adult growth hormone deficiency

Alliance Pharmaceutical submits documentation to the FDA regarding Imavist approval

Allergan's Botox approved for hyperhidrosis in the U.K.

FDA issues approvable letter for Arixtra

FDA approves labeling change for Pfizer's Zoloft

Compounds for delivery of biologically or chemically active agents designed at Emisphere

Kyoto Pharmaceuticals reports carbapenems active against respiratory and urinary tract infections

Novel MMP inhibitors disclosed by Aventis

Aventis develops a new series of Na+/H+ exchange inhibitors

FDA advisory committee recommends approval of Kineret for treatment of RA

Two series of glycogen synthase kinase 3 inhibitors patented by Chiron

Zometa approved by FDA for treatment of hypercalcemia of malignancy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...